Improving translational research, maximizing animal welfare, and developing alternatives
Biomedical research leads to new treatments, diagnostic tests and preventive measures. To produce these results, knowledge gained in the laboratory setting must be able to reach the patient, i.e. it must be ‘translated’ to clinical and community health care settings. This process is known as ‘translation’. The overriding goal of Charité 3R is to enhance this translation of research from bench to bedside.
Animal research continues to play an important role within the field of biomedical research. Charité 3R aims to advance animal welfare standards within the field and enhance the quality of unavoidable animal research. We are also determined to further the development of new alternatives to animal research.
Our name – Charité 3R – is based on the ‘principles of the 3Rs’ (Replacement, Reduction and Refinement). Initially developed by William Russell and Rex Burch, these three guiding principles advocate the use of methods which avoid or replace the use of animals in testing (Replacement), and minimize the number (Reduction) or the suffering of animals used in testing (Refinement).
Charité 3R promotes the development of such methods within Charité’s biomedical research endeavors, and works in close collaboration with the Forschungseinrichtungen für Experimentelle Medizin.
Charité 3R – events
27.10.2021 To 27.10.2021
EPAA Annual Conference 2021
How can EPAA help the successful implementation of the EU Chemical Strategy for Sustainability
Who should attend: Members of European and international 3Rs institutions, academics, NGOs, national regulatory authorities and the general public interested in progress achieved in implementing the 3Rs in Europe during the past year.
01.11.2021 To 03.11.2021
Preclinical Systematic Review & Meta-Analysis Course
03.11.2021 To 03.11.2021
13th annual Advances in Cell and Tissue Culture
The program for ACTC 2021 covers a wide range of interesting, relevant topics with a great line-up of keynote speakers anticipated.
04.11.2021 To 04.11.2021
BMEs and replacements from a research perspective
The second webinar on the challenges and opportunities of replacing BME’s explores different applicational areas, from basic research to preclinical drug development where BMEs can be replaced, and how the replacements can be incorporated into translation research.
09.11.2021 To 09.11.2021
Cell-based bioassays for Precisiontox
PrecisionTox "Café Scientifique" with Prof. Beate Escher - "Cell-based bioassays for Precisiontox ….. and what else can you do with them?"
18.11.2021 To 18.11.2021
BMEs and replacements for clinical application areas
The third webinar on the challenges and opportunities of replacing BME’s touches on diagnostics, regenerative medicine and the regulatory aspects of replacing BMEs.
22.11.2021 To 23.11.2021
New Approach Methodologies (NAMs)
Two-day Online Workshop focusing on animal-free New Approach Methodologies (NAMs) in biomedical research.
24.11.2021 To 24.11.2021
Einstein Foundation Award 2021
for Promoting Quality in Research
SAVE THE DATE - on November 24, the Einstein Foundation will announce the first-ever winners of the €500.000 Einstein Foundation Award for Promoting Quality in Research.
02.12.2021 To 02.12.2021
The future of BMEs and their replacements: A panel discussion
In the last webinar on the challenges and opportunities of replacing BME’s previous speakers come together to discuss the wider topic of replacing BMEs, and the 3Rs implications of the approached discussed.